Movement disorders and cerebrovascular diseases: from pathophysiology to treatment

References

• Abdo WF, van de Warrenburg BP, Burn DJ, et al. The clinical approach to movement disorders. Nat Rev Neurol. 2010;6:29–37.
   PubMed Web of Science ®Google Scholar
• Jankovic J, Lang A. Movement disorders: diagnosis and assessment. In: Neurology in clinical practice. Philadelphia (PA): Butterworth and Heinemann (Elsevier); 2004.
   Google Scholar
• Netravathi M, Pal PK, Indira Devi B. A clinical profile of 103 patients with secondary movement disorders: correlation of etiology with phenomenology. Eur J Neurol. 2012;19:226–233.
   PubMed Web of Science ®Google Scholar
• Scott BL, Jankovic J. Delayed-onset progressive movement disorders after static brain lesions. Neurology. 1996;46:68–74.
   PubMed Web of Science ®Google Scholar
• Ghika-Schmid F, Ghika J, Regli F, et al. Hyperkinetic movement disorders during and after acute stroke: the Lausanne stroke registry. J Neurol Sci. 1997;146:109–16.
   PubMed Web of Science ®Google Scholar
• Alarcon F, Zijlmans JC, Duenas G, et al. Post-stroke movement disorders: report of 56 patients. J Neurol Neurosurg Psychiatry. 2004;75:1568–1574.
   PubMed Web of Science ®Google Scholar
• Handley A, Medcalf P, Hellier K, et al. Movement disorders after stroke. Age Ageing. 2009;38:260–266.
   PubMed Web of Science ®Google Scholar
• Mehanna R, Jankovic J. Movement disorders in cerebrovascular disease. Lancet Neurol. 2013;12:597–608.
   PubMed Web of Science ®Google Scholar
• Stoessl AJ, Mckeown MJ. Movement disorders. Handb Clin Neurol. 2016;136:957–969.
   PubMedGoogle Scholar
• Kim JS. Delayed onset mixed involuntary movements after thalamic stroke clinical, radiological and pathophysiological findings. Brain. 2001;124:299–309.
   PubMed Web of Science ®Google Scholar
• Bansil S, Prakash N, Kaye J, et al. Movement disorders after stroke in adults: a review. Tremor Other Hyperkinet Mov. 2012;2. Available from http://tremorjournal.org/article/view/42
   Google Scholar
• Ghika J, Bogousslavsky J. Abnormal movements. In: Bogousslavsky J, Caplan L, editors. Stroke syndromes, 2nd edn. Cambridge: Cambridge University Press; 2001. p. 162–181.
   Google Scholar
• Calabresi P, Picconi B, Tozzi A, et al. Direct and indirect pathways of basal ganglia: a critical reappraisal. Nat Neurosci. 2014;17:1022–10230.
   PubMed Web of Science ®Google Scholar
• Poston KL, Eidelberg D. Functional brain networks and abnormal connectivity in the movement disorders. Neuroimage. 2012;62:2261–2270.
   PubMed Web of Science ®Google Scholar
• Helmich RC, Hallett M, Deuschl G, et al. Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits? Brain. 2012;135:3206–3226.
   PubMed Web of Science ®Google Scholar
• Baudrexel S, Witte T, Seifried C, et al. Resting state fMRI reveals increased subthalamic nucleus-motor cortex connectivity in Parkinson’s disease. Neuroimage. 2011;55:1728–1738.
   PubMed Web of Science ®Google Scholar
• Malek N, Lawton MA, Swallow DM, et al. Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson’s disease. Mov Disord. 2016;31:1518–1526.
   PubMed Web of Science ®Google Scholar
• Pilotto A, Turrone R, Liepelt-Scarfone I, et al. Vascular risk factors and cognition in Parkinson’s disease. J Alzheimers Dis. 2016;51:563–570.
   PubMed Web of Science ®Google Scholar
• Walters AS, Rye DB. Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke. Sleep. 2009;32:589–597.
   PubMed Web of Science ®Google Scholar
• Bekci TT, Kayrak M, Kiyici A, et al. The relation between Lp-PLA2 levels with periodic limb movements. Sleep Breath. 2012;16:117–122.
   PubMed Web of Science ®Google Scholar
• Lo RY, Figueroa KP, Pulst SM, et al. Vascular risk factors and clinical progression in spinocerebellar ataxias. Tremor Other Hyperkinet Mov (N Y). 2015;5:287.
   PubMedGoogle Scholar
• Bosco D, Plastino M, Cristiano D, et al. Dementia is associated with insulin resistance in patients with Parkinson’s disease. J Neurol Sci. 2012;315:39–43.
   PubMed Web of Science ®Google Scholar
• Miyake Y, Tanaka K, Fukushima W, et al. Case-control study of risk of Parkinson’s disease in relation to hypertension,hypercholesterolemia, and diabetes in Japan. J Neurol Sci. 2010;293:82–86.
   PubMed Web of Science ®Google Scholar
• Cereda E, Barichella M, Cassani E, et al. Clinical features of Parkinson disease when onset of diabetes came first: a case-control study. Neurology. 2012;78:1507–1511.
   PubMed Web of Science ®Google Scholar
• Cereda E, Barichella M, Pedrolli C, et al. Diabetes and risk of Parkinson’s disease: a systematic review and meta-analysis. Diabetes Care. 2011;34:2614–2623.
   PubMed Web of Science ®Google Scholar
• Patel M, Coutinho C, Emsley HC. Prevalence of radiological and clinical cerebrovascular disease in idiopathic Parkinson’s disease. Clin Neurol Neurosurg. 2011;113:830–834.
   PubMed Web of Science ®Google Scholar
• Veselý B, Rektor I. The contribution of white matter lesions (WML) to Parkinson’s disease cognitive impairment symptoms: a critical review of the literature. Parkinsonism Relat Disord. 2016;22(Suppl 1):S166–S170.
   PubMed Web of Science ®Google Scholar
• Kandiah N, Mak E, Ng A, et al. Cerebral white matter hyperintensity in Parkinson’s disease: a major risk factor for mild cognitive impairment. Parkinsonism Relat Disord. 2013;19:680–683.
   PubMed Web of Science ®Google Scholar
• Kandiah N, Zainal NH, Narasimhalu K, et al. Hippocampal volume and white matter disease in the prediction of dementia in Parkinson’s disease. Parkinsonism Relat Disord. 2014;20:1203–1208.
   PubMed Web of Science ®Google Scholar
• Veselý B, Antonini A, Rektor I. The contribution of white matter lesions to Parkinson’s disease motor and gait symptoms: a critical review of the literature. J Neural Transm (Vienna). 2016;123:241–250.
   PubMed Web of Science ®Google Scholar
• Sławek J, Roszmann A, Robowski P, et al. The impact of MRI white matter hyperintensities on dementia in Parkinson’s disease in relation to the homocysteine level and other vascular risk factors. Neurodegener Dis. 2013;12:1–12.
   PubMed Web of Science ®Google Scholar
• Paillard T, Rolland Y, de Souto Barreto P. Protective effects of physical exercise in Alzheimer’s disease and Parkinson’s disease: a narrative review. J Clin Neurol. 2015;11:212–219.
   PubMed Web of Science ®Google Scholar
• Swallow DM, Lawton MA, Grosset KA, et al. Statins are underused in recent-onset Parkinson’s disease with increased vascular risk: findings from the UK Tracking Parkinson’s and Oxford Parkinson’s Disease Centre (OPDC) discovery cohorts. J Neurol Neurosurg Psychiatry. 2016;87:1183–1190.
   Google Scholar
• Critchley M. Arteriosclerotic parkinsonism. Brain. 1929;52:23–83.
   Google Scholar
• Critchley M. Arteriosclerotic pseudoparkinsonism. In: Rose C, Capildeo R, editors. Research progress in Parkinson’s disease. London: Pitman Medical; 1981. p. 40–42.
   Google Scholar
• Schwab RS, England AC. Parkinson syndromes due to various specific causes. In: Vinken B, editor. Handbook of clinical neurology. Amsterdam: North-Holland Publishing Co; 1968.
   Google Scholar
• Parkes JD, Marsden CD, Rees JE, et al. Parkinson’s disease, cerebroarteriosclerosis, and senile dementia. Q J Med. 1974;43:49–61.
   PubMedGoogle Scholar
• Practice Management Information Corporation (Corporate Author) ICD-9-CM International Classification of Diseases, 9th Rev: Clinical Modification (ICD-9-CM Coder's Choice).2005;1–3.
   Google Scholar
• Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol. 1999;56:98–102.
   PubMed Web of Science ®Google Scholar
• Zijlmans JC, Daniel SE, Hughes AJ, et al. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord. 2004;19:630–640.
   PubMed Web of Science ®Google Scholar
• Inzelberg R, Bornstein NM, Reider I, et al. Basal ganglia lacunes and parkinsonism. Neuroepidemiology. 1994;13:108–112.
   PubMed Web of Science ®Google Scholar
• Benítez-Rivero S, Lama MJ, Huertas-Fernández I, et al. Clinical features and neuropsychological profile in vascular parkinsonism. J Neurol Sci. 2014;345:193–197.
   PubMed Web of Science ®Google Scholar
• Jellinger KA. Vascular parkinsonism-neuropathological findings. Acta Neurol Scand. 2002;105:414–415.
   PubMed Web of Science ®Google Scholar
• Kalra S, Grosset DG, Benamer HT. Differentiating vascular parkinsonism from idiopathic Parkinson’s disease: a systematic review. Mov Disord. 2010;25:149–156.
   PubMed Web of Science ®Google Scholar
• Abe K, Yanagihara T. Hemiparkinsonism following haemorrhage in the contralateral substantia nigra. Neuroradiology. 1996;38(S1):S67–S69.
   PubMed Web of Science ®Google Scholar
• Inoue H, Udaka F, Takahashi M, et al. Secondary parkinsonism following midbrain hemmorage. Rinsho Shinkeigaku. 1997;37:266–269.
   PubMedGoogle Scholar
• Defer GL, Remy P, Malapert D, et al. Rest tremor and extrapyramidal symptoms after midbrain haemorrhage: clinical and 18F-dopa PET evaluation. J Neurol Neurosurg Psychiatry. 1994;57:987–989.
   PubMed Web of Science ®Google Scholar
• Ertan S, Fresko I, Apaydin H, et al. Extrapiramidal type rigidity in rheumatoid arthritis. Rheumatology (Oxford). 1999;38:627–630.
   PubMed Web of Science ®Google Scholar
• Hrycaj P, Korczowska I, Lacki JK. Severe Parkinson’s disease in rheumatoid arthritis patient treated with infliximab. Rheumatology (Oxford). 2003;42:702–703.
   PubMed Web of Science ®Google Scholar
• Yoritaka A, Hattori T, Hattori Y, et al. A 85-year-old woman with the onset of progressive gait disturbance at 80 years of age. No To Shinkei. 1997;49:379–389.
   PubMedGoogle Scholar
• Pineda DA, Buritica O, Sanchez JL, et al. Parkinsonian syndromes in Medellin (Colombia). Rev Neurol. 2000;31:936–943.
   PubMed Web of Science ®Google Scholar
• Tan EK, Chan LL, Auchus AP. Reversible parkinsonism in systemic lupus erythematosus. J Neurol Sci. 2001;193:53–57.
   PubMed Web of Science ®Google Scholar
• Korczyn AD. Vascular parkinsonism–characteristics, pathogenesis and treatment. Nat Rev Neurol. 2015;11:319–326.
   PubMed Web of Science ®Google Scholar
• Garcia-Moreno JM, Chacon J. Juvenile parkinsonism as a manifestation of systemic lupus erythematosus: case report and review of the literature. Mov Disord. 2002;17:1329–1335.
   PubMed Web of Science ®Google Scholar
• Milanov I, Bogdanova D. Antiphospholipid syndrome and dystonia-parkinonism A case report. Parkinsonism Relat Disord. 2001;7:139–141.
   PubMed Web of Science ®Google Scholar
• Adhiyaman V, Meara RJ, Bhowmick, BK. Antiphospholipid syndrome and dystonia-parkinsonim: need for anticoagulation. Parkinsonism Relat Disord. 2002;8:215.
   PubMed Web of Science ®Google Scholar
• Huang Z, Jacewicz M, Pfeiffer RF. Anticardiolipin antibody in vascular parkinsonism. Mov Disord. 2002;17:992–997.
   PubMed Web of Science ®Google Scholar
• Fabiani G, Teive HA, Germiniani FM, et al. Reversible parkinsonian syndrome in systemic and brain vasculitis. Mov Disord. 2002;17:601–604.
   PubMed Web of Science ®Google Scholar
• Cosi V, Tonali P. Acute Parkinson syndrome following subarachnoid hemorrhage in a schizophrenic subject. Riv Patol Nerv Ment. 1964;85:287–301.
   PubMedGoogle Scholar
• Pau A, Brambilla M, Cossu M, et al. Parkinsonism in the presence of intracranial extracerebralhaematomas. Acta Neurochir (Wien). 1989;96:159–160.
   PubMed Web of Science ®Google Scholar
• Trosch RM, Ransom BR. Levodopa-responsive parkinsonism following central herniation due to bilateral subdural hematomas. Neurology. 1990;40:376–377.
   PubMed Web of Science ®Google Scholar
• Turjanski N, Pentland B, Lees AJ, et al. Parkinsonism associated with acute intracranial hematomas: an [18F] dopa positron-emission tomography study. Mov Disord. 1997;12:1035–1038.
   PubMed Web of Science ®Google Scholar
• Miyagi K, Imaizumi T, Nagura H, et al. A case of transient parkinsonism due to mesencephalic hemorrhage. Rinsho Shinkeigaku. 1992;32:743–746.
   PubMedGoogle Scholar
• Kim JS. Involuntary movements after anterior cerebral artery territory infarction. Stroke. 2001;32:258–261.
   PubMed Web of Science ®Google Scholar
• Defebvre L, Krystkowiak P. Movement disorders and stroke. Rev Neurol (Paris). 2016;172:483–487.
   PubMed Web of Science ®Google Scholar
• Friedman A, Kang UJ, Tatemichi TK, et al. A case of parkinsonism following striatal lacunar infarction. J Neurol Neurosurg Psychiatry. 1986;49:1087–1088.
   PubMed Web of Science ®Google Scholar
• Lazzarino LG, Nicolai A, Toppani D. Subacute parkinsonism from a single lacunar infarct in the basal ganglia. Acta Neurol (Napoli). 1990;12:292–295.
   PubMedGoogle Scholar
• Murrow RW, Schweiger GD, Kepes JJ, et al. Parkinsonism due to a basal ganglia lacunar state: clinicopathologic correlation. Neurology. 1990;40:897–900.
   PubMed Web of Science ®Google Scholar
• Kulisevsky J, Berthier ML, Avila A, et al. Unilateral parkinsonism and stereotyped movements following a right lenticular infarction. Mov Disord. 1996;11:752–754.
   PubMed Web of Science ®Google Scholar
• Fenelon G, Houeto JL. Unilateral parkinsonism following a large infarct in the territory of the lenticulostriate arteries. Mov Disord. 1997;12:1086–1090.
   PubMed Web of Science ®Google Scholar
• Sibon I, Guyot M, Allard M, et al. Parkinsonism following anterior choroidal artery stroke. Eur J Neurol. 2004;11:283–284.
   PubMed Web of Science ®Google Scholar
• Choi IS. Parkinsonism after carbon monoxide poisoning. Eur Neurol. 2002;48:30–33.
   PubMed Web of Science ®Google Scholar
• Zijlmans JC, Thijssen HO, Vogels OJ, et al. MRI in patients with suspected vascular parkinsonism. Neurology. 1995;45:2183–2188.
   PubMed Web of Science ®Google Scholar
• Chen YF, Tseng YL, Lan MY, et al. The relationship of leukoaraiosis and the clinical severity of vascular Parkinsonism. J Neurol Sci. 2014;346:255–259.
   PubMed Web of Science ®Google Scholar
• Piccini P, Pavese N, Canapicchi R, et al. White matter hyperintensities in Parkinson’s disease .Clinical correlations. Arch Neurol. 1995;52:191–194.
   PubMedGoogle Scholar
• Reider-Groswasser I, Bornstein NM, Korczyn AD. Parkinsonism in patients with lacunar infarcts of the basal ganglia. Eur Neurol. 1995;35:46–49.
   PubMed Web of Science ®Google Scholar
• Bergman H, Deuschl G. Pathophysiology of Parkinson’s disease: from clinical neurology to basic neuroscience and back. Mov Disord. 2002;17(Suppl 3):S28–S40.
   PubMed Web of Science ®Google Scholar
• Tzen KY, Lu CS, Yen TC, et al. Differential diagnosis of Parkinson’s disease and vascular parkinsonism by (99m)Tc-TRODAT-1. J Nucl Med. 2001;42:408–413.
   PubMed Web of Science ®Google Scholar
• Lorberboym M, Djaldetti R, Melamed E, et al. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism. J Nucl Med. 2004;45:1688–1693.
   PubMed Web of Science ®Google Scholar
• Behnke S, Berg D, Naumann M, et al. Differentiation of Parkinson’s disease and atypical parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry. 2005;76:423–425.
   PubMed Web of Science ®Google Scholar
• Katzenschlager R, Zijlmans J, Evans A, et al. Olfactory function distinguishes vascular parkinsonism from Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2004;75:1749–1752.
   PubMed Web of Science ®Google Scholar
• Goldstein DS. Functional neuroimaging of sympathetic innervation of the heart. Ann NY Acadsci. 2004;1018:231–243.
   PubMed Web of Science ®Google Scholar
• Hardoff R, Sula M, Tamir A, et al. Gastric emptying time and gastric motility in patients with Parkinson’s disease. Mov Disord. 2001;16:1041–1047.
   PubMed Web of Science ®Google Scholar
• Antonini A, Vitale C, Barone P, et al. The relationship between cerebral vascular disease and parkinsonism: the VADO study. Parkinsonism Relat Disord. 2012;18:775–780.
   PubMed Web of Science ®Google Scholar
• Solla P, Cannas A, Arca R, et al. Focal (123)I-FP-CIT SPECT abnormality in midbrain vascular parkinsonism. Case Rep Neurol Med. 2015;2015:642764.
   PubMedGoogle Scholar
• Xu Y, Wei X, Liu X, et al. Low cerebral glucose metabolism: a potential predictor for the severity of vascular parkinsonism and Parkinson’s disease. Aging Dis. 2015;6:426–436.
   PubMed Web of Science ®Google Scholar
• Mostile G, Nicoletti A, Cicero CE, et al. Magnetic resonance parkinsonism index in progressive supranuclear palsy and vascular parkinsonism. Neurol Sci. 2016;37:591–595.
   PubMed Web of Science ®Google Scholar
• Ray Chaudhuri K, Ondo W. Parkinsonian syndromes. In Handbook of movement disorders Springer science & business media.  London: Springer-Verlag; 2011.
   Google Scholar
• Vizcarra JA, Lang AE, Sethi KD, et al. Vascular parkinsonism: deconstructing a syndrome. Mov Disord. 2015;307:886–894.
   Web of Science ®Google Scholar
• Jankovic J, Tolosa E. Parkinson’s disease and movement disorders. 6th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2015.
   Google Scholar
• Balash Y, Korczyn AD. Vascular parkinsonism. In: Koller WC, Melamed E, editors. Handbook of clinical neurology, Vol. 84 (3rd series) Parkinson’s disease and related disorders, Part II. Amsterdam: Elsevier; 2007.
   Google Scholar
• Jellinger KA. Vascular parkinsonism. Therapy. 2008;5:238–255.
   Google Scholar
• Thomas M, Jankovic J. Clinical diagnosis of vascular parkinsonism and non-degenerative atypical parkinsonian disorders. In: Litvan I, editor. Current clinical neurology: atypical parkinsonian disorders. Totowa (NJ): Humana Press; 2005. p. 393–408.
   Google Scholar
• Paraskevas GP, Kapaki E, Petropoulou O, et al. Plasma levels of antioxidant vitamins C and E are decreased in vascular parkinsonism. J Neurol Sci. 2003;215:51–55.
   PubMed Web of Science ®Google Scholar
• Ondo WG, Chan LL, Levy JK. Vascular parkinsonism: clinical correlates predicting motor improvement after lumbar puncture. Mov Disord. 2002;17:91–97.
   PubMed Web of Science ®Google Scholar
• Matsuda S, Waragai M, Shinotoh H, et al. Intracranial dural arteriovenous fistula (DAVF) presenting progressive dementia and parkinsonism. J Neurol Sci. 1999;165:43–47.
   PubMed Web of Science ®Google Scholar
• Lee PH, Lee JS, Shin DH, et al. Parkinsonism as an initial manifestation of dural arteriovenous fistula. Eur J Neurol. 2005;12:403–406.
   PubMed Web of Science ®Google Scholar
• Kajitani M, Yagura H, Kawahara M, et al. Treatable fluctuating parkinsonism and dementia in a patient with a dural arteriovenous fistula. Mov Disord. 2007;22:437–439.
   PubMed Web of Science ®Google Scholar
• Nogueira RG, Baccin CE, Rabinov JD. Reversible parkinsonism after treatment of dural arteriovenous fistula. J Neuroimaging. 2009;19:183–184.
   PubMed Web of Science ®Google Scholar
• Miura S, Noda K, Shiramizu N, et al. Parkinsonism and ataxia associated with an intracranial dural arteriovenous fistula presenting with hyperintense basal ganglia in T1-weighted MRI. J Clin Neurosci. 2009;16:341–343.
   PubMed Web of Science ®Google Scholar
• Netravathi M, Pal PK, Bharath RD, et al. Intracranial dural arteriovenous fistula presenting as parkinsonism and cognitive dysfunction. J Clin Neurosci. 2011;18:138–140.
   PubMed Web of Science ®Google Scholar
• Kreisler A, Mastain B, Tison F, et al. Multi-infarct disorder presenting as corticobasal degeneration (DCB): vascular pseudo-corticobasal degeneration? Rev Neurol. 2007;163:1191–1199.
   PubMed Web of Science ®Google Scholar
• Kim YD, Kim JS, Lee ES, et al. Progressive “vascular” corticobasal syndrome due to bilateral ischemic hemispheric lesions. Intern Med. 2009;48:1699–16702.
   PubMed Web of Science ®Google Scholar
• Winikates J, Jankovic J. Vascular progressive supranuclear palsy. J Neural Transm. 1994;42:189–201.
   Google Scholar
• Mark MH, Sage JI, Walters AS, et al. Binswanger’s disease presenting as levodopa-responsive parkinsonism: clinicopathologic study of three cases. Mov Disord. 1995;10:450–454.
   PubMed Web of Science ®Google Scholar
• Josephs KA, Ishizawa T, Tsuboi Y, et al. A clinicopathological study of vascular progressive supranuclear palsy: a multi-infarct disorder presenting as progressive supranuclear palsy. Arch Neurol. 2002;59:1597–1601.
   PubMedGoogle Scholar
• Postuma RB, Lang AE. Hemiballism: revisiting a classic disorder. Lancet Neurol. 2003;2:661–668.
   PubMed Web of Science ®Google Scholar
• Zidverc-Trajković J, Jovanović DR, Marjanović I, et al. Successful intravenous thrombolysis in a stroke patient with hemiballism. Neurologist. 2011;17:205–207.
   PubMed Web of Science ®Google Scholar
• Correnti A, Toni D, Colosimo C. Thrombolysis in hemiballism: is it a rational choice? Intern Emerg Med. 2012;7(Suppl 2):S125–S126.
   PubMed Web of Science ®Google Scholar
• McCollum D, Silvers S, Dawson SB, et al. Resolution of acute onset hemichorea-hemiballismus after treatment with intravenous tissue plasminogen activator. Neurohospitalist. 2012;3:131–134.
   Google Scholar
• Zagnoli F, Rouhart F, Perotte P, et al. Hemichorea and striatal infarction. Rev Neurol. 1996;152:615–622.
   PubMed Web of Science ®Google Scholar
• Chang MH, Chiang HT, Lai PH, et al. Putaminal petechial haemorrhage as the cause of chorea: a neuroimaging study. J Neurol Neurosurg Psychiatry. 1997;63:300–303.
   PubMed Web of Science ®Google Scholar
• Chung SJ, Im JH, Lee MC, et al. Hemichorea after stroke: clinical-radiological correlation. J Neurol. 2004;251:725–729.
   PubMed Web of Science ®Google Scholar
• Park SY, Kim HJ, Cho YJ, et al. Recurrent hemichorea following a single infarction in the contralateral subthalamic nucleus. Mov Disord. 2009;24:617–618.
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Aoyama N, Sasaki J, et al. MRI appearance of a cerebral cavernous malformation in the caudate nucleus before and after chorea onset. J Clin Neurosci. 2011;18:719–721.
   PubMed Web of Science ®Google Scholar
• Shimizu T, Hiroki M, Yamaoka Y, et al. Alternating paroxysmal hemiballism-hemichorea in bilateral internal carotid artery stenosis. Intern Med. 2001;40:808–812.
   PubMed Web of Science ®Google Scholar
• Morigaki R, Uno M, Suzue A, et al. Hemichorea due to hemodynamic ischemia associated with extracranial carotid artery stenosis report of two cases. J Neurosurg. 2006;105:142–147.
   PubMed Web of Science ®Google Scholar
• Pareés I, Pujadas F, Hernández-Vara J, et al. Reversible hemichorea associated with extracranial carotid artery stenosis. J Neurol Sci. 2001;300:185–186.
   Web of Science ®Google Scholar
• Schwarz GA, Barrows LJ. Hemiballism without involvement of Luys’s body. Arch Neurol. 1960;2:420–434.
   PubMedGoogle Scholar
• Lang AE. Persistent hemiballism with lesions outside the subthalamic nucleus. Can J Neurol Sci. 1985;12:125–128.
   PubMed Web of Science ®Google Scholar
• Vidakovic A, Dragasevic N, Kostic VS. Hemiballism: report of 25 cases. J Neurol Neurosurg Psychiatry. 1994;57:945–949.
   PubMed Web of Science ®Google Scholar
• Rossetti AO, Ghika JA, Vingerhoets F, et al. Neurogenic pain and abnormal movements contralateral to an anterior parietal artery stroke. Arch Neurol. 2003;60:1004–1006.
   PubMedGoogle Scholar
• Etgen T, Winbeck K, Conrad B, et al. Hemiballism with insular infarction as first manifestation of Takayasu’s arteritis in association with chronic hepatitis B. J Neurol. 2003;250:226–229.
   PubMed Web of Science ®Google Scholar
• Tai ML, Tan CT, Ramli N, et al. Movement disorder in a patient with stroke. J Clin Neurosci. 2011;18:263–305.
   PubMed Web of Science ®Google Scholar
• Shrestha P, Adhikari J, Poudel D, et al. Cortical hemiballism: a case of hemiballismus associated with parietal lobe infarct. N Am J Med Sci. 2015;7:572–574.
   PubMed Web of Science ®Google Scholar
• Sharp FR, Rando TA, Greenberg SA, et al. Pseudochoreoathetosis movements associated with loss of proprioception. Arch Neurol. 1994;51:1103–1109.
   PubMedGoogle Scholar
• Salih F, Zimmer C, Meierkord H. Parietal proprioceptive loss with pseudoathetosis. J Neurol. 2007;254:396–397.
   PubMed Web of Science ®Google Scholar
• Lee MS, Kim YD, Kim JT, et al. Abrupt onset of transient pseudochoreoathetosis associated with proprioceptive sensory loss as a result of a thalamic infarction. Mov Disord. 1998;13:184–186.
   PubMed Web of Science ®Google Scholar
• Jankovic J, Clarence-Smith K. Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders. Expert Rev Neurother. 2011;11:1509–1523.
   PubMed Web of Science ®Google Scholar
• Driver-Dunckley E, Evidente VG. Hemichorea-hemiballismus may respond to topiramate. Clin Neuropharmacol. 2005;28:142–144.
   PubMed Web of Science ®Google Scholar
• Astradsson A, Schweder P, Joint C, et al. Thalamotomy for postapoplectichemiballistic chorea in older adults. J Am Geriatr Soc. 2010;58:2240–2241.
   PubMed Web of Science ®Google Scholar
• Franzini A, Cordella R, Messina G, et al. Deep brain stimulation for movement disorders considerations on 276 consecutive patients. J Neural Transm. 2011;118:1497–1510.
   PubMed Web of Science ®Google Scholar
• Tseng KY, Tang CT, Chang CF, et al. Treatment of delayed-onset post-stroke monochorea with stereotactic pallidotomy. J Clin Neurosci. 2010;17:779–781.
   PubMed Web of Science ®Google Scholar
• Colosimo C, Berardelli A. Clinicalphenomenology of dystonia. Int Rev Neurobiol. 2011;98:509–524.
   PubMed Web of Science ®Google Scholar
• Chuang C, Fahn S, Frucht SJ. The natural history and treatment of acquired hemidystonia: report of 33 cases and review of the literature. J Neurol Neurosurg Psychiatry. 2002;72:59–67.
   PubMed Web of Science ®Google Scholar
• Sibon I, Burbaud P. Risussardonicus after thalamic haemorrhage. Mov Disord. 2004;19:829–831.
   PubMed Web of Science ®Google Scholar
• Béjot Y, Giroud M, Moreau T, et al. Clinical spectrum of movement disorders after stroke in childhood and adulthood. Eur Neurol. 2012;68:59–64.
   PubMed Web of Science ®Google Scholar
• Giordano A, Tedeschi G, Tessitore A. Vascular-inducedcompensatory pseudo-retrocollis. Neurology. 2015;84:2005–2006.
   PubMed Web of Science ®Google Scholar
• Sabrie M, Berhoune N, Nighoghossian N. Alien hand syndrome and paroxystic dystonia after right posterior cerebral artery territory infarction. Neurol Sci. 2015;36:1709–1710.
   PubMed Web of Science ®Google Scholar
• Ghika J, Bogousslavsky J, Henderson J, et al. The “jerky dystonic unsteady hand”: a delayed motor syndrome in posterior thalamic infarctions. J Neurol. 1994;241:537–542.
   PubMed Web of Science ®Google Scholar
• Lehericy S, Vidailhet M, Dormont D, et al. Striatopallidal and thalamic dystonia. Arch Neurol. 1996;53:241–250.
   PubMedGoogle Scholar
• Krystkowiak P, Martinat P, Defebvre L, et al. Dystonia after striatopallidal and thalamic stroke: clinicoradiological correlations and pathophysiological mechanisms. J Neurol Neurosurg Psychiatry. 1998;65:703–708.
   PubMed Web of Science ®Google Scholar
• Wijemanne S, Jankovic J. Hemidystonia-hemiatrophy syndrome. Mov Disord. 2009;24:583–589.
   PubMed Web of Science ®Google Scholar
• Usmani N, Bedi GS, Sengun C, et al. Late onset of cervical dystonia in a 39-year-old patient following cerebellar hemorrhage. J Neurol. 2011;258:149–151.
   PubMed Web of Science ®Google Scholar
• Jankovic J, Patel SC. Blepharospasm associated with brainstem lesions. Neurology. 1983;33:1237–1240.
   PubMed Web of Science ®Google Scholar
• Marsden CD, Obeso JA, Zarranz JJ, et al. The anatomical basis of symptomatic hemidystonia. Brain. 1985;108:463–483.
   PubMed Web of Science ®Google Scholar
• Pettigrew LC, Jankovic J. Hemidystonia: a report of 22 patients and review of the literature. J Neurol Neurosurg Psychiatry. 1985;48:650–657.
   PubMed Web of Science ®Google Scholar
• Lee MS, Marsden CD. Review: movement disorders following lesions of the thalamus or subthalamic region. Mov Disord. 1994;9:493–507.
   PubMed Web of Science ®Google Scholar
• Bhatia KP, Marsden CD. The behavioral and motor consequences of focal lesions of the basal ganglia in man. Brain. 1994;117:859–876.
   PubMed Web of Science ®Google Scholar
• Vidailhet M, Dupel C, Lehéricy S, et al. Dopaminergic dysfunction in midbrain dystonia: anatomoclinical study using 3-dimensional magnetic resonance imaging and fluorodopa F 18 positron emission tomography. Arch Neurol. 1999;56:982–989.
   PubMedGoogle Scholar
• Jankovic J. Treatment of hyperkinetic movement disorders. Lancet Neurol. 2009;8:844–856.
   PubMed Web of Science ®Google Scholar
• Pin TW, Elmasry J, Lewis J. Efficacy of botulinum toxin A in children with cerebral palsy in gross motor function classification system levels IV and V: a systematic review. Dev Med Child Neurol. 2013;55:304–313.
   PubMed Web of Science ®Google Scholar
• Ferbert A, Gerwig M. Tremor due to stroke. Mov Disord. 1993;8:179–182.
   PubMed Web of Science ®Google Scholar
• Miwa H, Hatori K, Kondo T, et al. Thalamic tremor: case reports and implications of the tremor generating mechanism. Neurology. 1996;46:75–79.
   PubMed Web of Science ®Google Scholar
• Nowak DA, Seidel B, Reiner B. Tremor following ischemic stroke of the posterior thalamus. J Neurol. 2010;257:1934–1936.
   PubMed Web of Science ®Google Scholar
• Deuschl G, Bain P, Brin M. Consensus statement of the movement disorders society on tremor Ad hoc scientific committee. Mov Disord. 1998;13(suppl 3):2–23.
   PubMed Web of Science ®Google Scholar
• Raina GB, Cersosimo MG, Folgar SS, et al. Holmes tremor: clinical description, lesion localization, and treatment in a series of 29 cases. Neurology. 2016;86:931–938.
   PubMed Web of Science ®Google Scholar
• Martins WA, Marrone LC, Fussiger H, et al. Holmes’ tremor as a delayed complication of thalamic stroke. J Clin Neurosci. 2016;26:158–159.
   PubMed Web of Science ®Google Scholar
• Colosimo C. ‘Abnormal’ DaTSCAN in a case of unilateral hand tremor associated with caudate infarct. Parkinsonism Relat Disord. 2010;16:356–357.
   PubMed Web of Science ®Google Scholar
• Katayama Y, Yamamoto T, Kobayashi K, et al. Deep brain and motor cortex stimulation for post-stroke movement disorders and post-stroke pain. Acta Neurochir Suppl. 2003;87:121–123.
   PubMedGoogle Scholar
• Yamamoto T, Katayama Y, Kano T, et al. Deep brain stimulation for the treatment of parkinsonian, essential, and poststroke tremor: a suitable stimulation method and changes in effective stimulation intensity. J Neurosurg. 2004;101:201–229.
   PubMed Web of Science ®Google Scholar
• Lyons KE, Pahwa R. Deep brain stimulation and tremor. Neurotherapeutics. 2008;5:331–338.
   PubMed Web of Science ®Google Scholar
• Jankovic J. Therapeutic developments for tics and myoclonus. Mov Disord. 2015;30:1566–1573.
   PubMed Web of Science ®Google Scholar
• Gatto EM, Zurrú MC, Rugilo C, et al. Focal myoclonus associated with posterior thalamic hematoma. Mov Disord. 1998;13:182–184.
   PubMed Web of Science ®Google Scholar
• Santos AF, Rocha S, Varanda S, et al. Hypertrophic olivary degeneration and cerebrovascular disease: movement in a triangle. J Stroke Cerebrovasc Dis. 2004;24:e59–e60.
   Web of Science ®Google Scholar
• Hanakawa T, Hashimoto S, Iga K, et al. Carotid brainstem reflex myoclonus after hypoxic brain damage. J Neurol Neurosurg Psychiatry. 2000;69:672–674.
   PubMed Web of Science ®Google Scholar
• Coelho M, Marti MJ, Valls-Solé J, et al. Left hemibody myoclonus due to anomalous right vertebral artery. Mov Disord. 2005;20:72–75.
   PubMed Web of Science ®Google Scholar
• Goyal M, Versnick E, Tuite P, et al. Hypertrophic olivary degeneration: metaanalysis of the temporal evolution of MR findings. AJNR Am J Neuroradiol. 2000;21:1073–1077.
   PubMed Web of Science ®Google Scholar
• Cerrato P, Grasso M, Azzaro C, et al. Palatal myoclonus in a patient with a lateral thalamic infarction. Neurology. 2005;64:924–925.
   PubMed Web of Science ®Google Scholar
• Inoa V, McCullough LD. Generalized myoclonus: a rare manifestation of stroke. Neurohospitalist. 2015;5:28–31.
   PubMedGoogle Scholar
• Kim JS. Asterixis after unilateral stroke: lesion location of 30 patients. Neurology. 2001;56:533–536.
   PubMed Web of Science ®Google Scholar
• Baizabal-Carvallo JF, Cardoso F, Jankovic J. Myorhythmia:phenomenology, etiology, and treatment. Mov Disord. 2015;30:171–179.
   PubMed Web of Science ®Google Scholar
• Sechi G, Sechi E. Restless legs syndrome and cerebrovascular disease. Lancet Neurol. 2013;12:734.
   PubMed Web of Science ®Google Scholar
• Maraganore DM, Lees AJ, Marsden CD. Complex stereotypies after right putaminal infarction: a case report. Mov Disord. 1991;6:358–361.
   PubMed Web of Science ®Google Scholar
• Ghika J, Bogousslavsky J, van Melle G, et al. Hyperkinetic motor behaviors contralateral to hemiplegia in acute stroke. Eur Neurol. 1995;35:27–332.
   PubMed Web of Science ®Google Scholar
• Yochelson MR, David RG. New-onset tic disorder following acute hemorrhage of an arteriovenous malformation. J Child Neurol. 2000;15:769–771.
   PubMed Web of Science ®Google Scholar